App-Quantinova.ai

Venous Thromboembolism in Hospitalized Medical Cancer Patients with and without Chemotherapy Infusion through Peripherally Inserted Central Catheters

S. Kaatz - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Venous thrombosis

Methadone hydrochloride

Accuracy of the Ottawa Score in Risk Stratification of Recurrent Venous Thromboembolism in Patients with Cancer‐associated Venous Thromboembolism. A Systematic Review and Meta‐analysis

A. Delluc - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Venous thrombosis

N/A

Clinical Risk Prediction Model for Venous Thromboembolism (VTE) in Allogeneic Blood or Marrow Transplant (BMT) Survivors

R. Gangaraju - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

N/A

Evaluation of Outpatient Management in Patients with Cancer‐associated Venous Thromboembolism

S.V. Hendriks - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Venous thrombosis

N/A

Full Benefit of Rivaroxaban Prophylaxis in High‐risk Ambulatory Cancer Patients: An Analysis of All Thromboembolic Events in CASSINI

A. Khorana - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

rivaroxaban

Efficacy and Safety of Rivaroxaban Thromboprophylaxis by Khorana Score Category: A Subgroup Analysis of CASSINI

A. Khorana - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Venous thrombosis

rivaroxaban

Association of Complete Blood Count Parameters, d‐Dimer and Soluble P‐selectin with Risk of Arterial Thromboembolism in Patients with Cancer

E. Grilz - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Venous thrombosis

N/A

Relative Risk of Arterial and Venous Thromboembolism in Persons with Cancer versus Persons without Cancer ‐ A Nation‐wide Analysis

E. Grilz - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

N/A

Apixaban as Treatment for Cancer Related Venous Thrombosis ‐ A Single Arm Interventional Study

T.-L. Hannevik - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Venous thrombosis

apixaban

Anticoagulant Treatment for Venous Thromboembolism in Myeloproliferative Neoplasms: A Systematic Review

E.N. Hamulyk - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Nephrology

Venous thrombosis

Heparin

The Ottawa Score Does Not Predict Recurrent Venous Thromboembolism in Cancer Patients: Results from the Hokusai‐VTE Cancer Study

F.T.M. Bosch - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Venous thrombosis

dalteparin Subcutaneous

Incidence, Risk Factors and Clinical Outcomes of Venous Thromboembolism in Patients with Pancreatic Cancer: Insights from the BACAP Cohort

C. Frere - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Venous thrombosis

N/A

Bleeding in the Prevention of Cancer‐associated Venous Thromboembolism: Secondary Analysis of the AVERT Study

L.A. Castellucci - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Venous thrombosis

N/A

Incidence of Venous Thromboembolism in Patients with Advanced Stage Cervico‐uterine Cancer

A. Priego-Ranero - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Venous thrombosis

N/A

Venous and Arterial Thrombosis in Myeloproliferative Neoplasms

L. Sukrisman - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Venous thrombosis

N/A

Portal Vein Thrombosis as a Prognostic Factor for Survival Rate in Liver Cirrhosis with Hepatocellular Carcinoma Patients

A. Kurniawan - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

N/A

Incidentally Detected Venous Thromboembolism in Cancer Patients: Results from the Hokusai VTE Cancer Trial

F. Mulder - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Venous thrombosis

dalteparin Subcutaneous

Incidence of Venous Thromboembolism (VTE) in Childhood Cancers ‐ Tertiary Care Centre Experience from Kingdom of Saudi Arabia

M. Saleh - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

N/A

DOACs and Cancer‐associated Thrombosis: Effect of Online CME on Knowledge and Confidence of Physicians

J. Spyropoulos - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Venous thrombosis

N/A

Prospective Registry of Cancer and Events Involving Venous Thromboembolism (PERCEIVE): 12‐month Outcomes

G. Petralia - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Venous thrombosis

N/A

Filters

7277 Abstracts